In-vivo-validation of a cardiovascular risk prediction tool: The arriba-pro study

BMC Family Practice

Volumn 14, Issue , 2013, Pages

  Diener, Annette ^a   Celemín Heinrich, Salomé ^b   Wegscheider, Karl ^c   Kolpatzik, Kai ^d   Tomaschko, Katrin ^e   Altiner, Attila ^a   Donner Banzhoff, Norbert ^b   Haasenritter, Jörg ^b  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Federal Association of the AOK   (Germany)

^e Deputy Head of Statutory Health Insurer AOK Baden Württemberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER PROGRAM; GERMANY; HUMAN; METHODOLOGY; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT; VALIDATION STUDY;

ALGORITHMS; CARDIOVASCULAR DISEASES; GERMANY; HUMANS; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RESEARCH DESIGN; RISK ASSESSMENT; SOFTWARE;

MLCS; MLOWN;

EID: 84872476389     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-14-13     Document Type: Article

References (26)

1. World Heart Day 2002: The International Burden of Cardiovascular Disease: Responding to the Emerging Global Epidemic. Bonow RO, Circulation 2002 106 1602 5 10.1161/01.CIR.0000035036.22612.2B 12270848
2. WHO, Cardiovascular Diseases (CVDs) Fact sheet No317 2012 available from http://www.who.int/mediacentre/factsheets/fs317/en/
3. Destatis, Statistisches Bundesamt, Anzahl der Gestorbenen nach ausgewählten Todesursachen 2011 2012 available from https://www.destatis. de/DE/ZahlenFakten/GesellschaftStaat/Gesundheit/Todesursachen/Tabellen/ EckdatenTU.html
4. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual' s absolute cardiovascular risk. Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A, Lancet 2005 365 434 41 15680460 (Pubitemid 40179232)
5. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Smith SC, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, Wood DA, Alderman M, Horgan J, Home P, Hunn M, Grundy SM, Circulation 2004 109 3112 21 10.1161/01.CIR.0000133427.35111.67 15226228
6. Individualized guidelines: the potential for increasing quality and reducing costs. Eddy DM, Adler J, Patterson B, Lucas D, Smith KA, Morris M, Ann Intern Med 2011 154 627 34 21536939
7. Cardiovascular disease risk profiles. Anderson KM, Odell PM, Wilson PW, Kannel WB, Am Heart J 1991 121 293 8 10.1016/0002-8703(91)90861-B 1985385
8. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S, BMJ 2003 327 1267 72 10.1136/bmj.327.7426.1267 14644971
9. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Hense H, Eur Heart J 2003 24 937 45 10.1016/S0195-668X(03)00081-2 12714025 (Pubitemid 36559987)
10. Prediction of first coronary events with the Framingham score: a systematic review. Eichler K, Puhan MA, Steurer J, Bachmann LM, Am Heart J 2007 153 722 31 731.e1-8 10.1016/j.ahj.2007.02.027 17452145 (Pubitemid 46628793)
11. Economic burden of cardiovascular diseases in the enlarged European Union. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M, Eur Heart J 2006 27 1610 9 10.1093/eurheartj/ehi733 16495286 (Pubitemid 43954923)
12. World's largest study of heart disease, stroke, risk factors, and population trends, 1979-2002. MONICA, Monograph and multimedia sourcebook World Health Organization, Geneva, Tunstall-Pedoe H, 2003
13. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH, Ann Intern Med 2004 141 421 31 15381515
14. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S, Lancet 2004 364 849 57 10.1016/S0140-6736(04)16980-8 15351192 (Pubitemid 39221062)
15. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer WM, Am J Respir Crit Care Med 2010 181 566 77 10.1164/rccm.200906-0907OC 20019345
16. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA, Psychother Psychosom 2008 77 219 26 10.1159/000126073 18418028 (Pubitemid 351685446)
17. Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled Trial. Krones T, Keller H, Sadowski E, Baum E, Wegscheider K, Rochon J, Donner-Banzhoff N, Ann Fam Med 2008 6 218 27 10.1370/afm.854 18474884 (Pubitemid 351720820)
18. Evaluation komplexer Interventionen: Implementierung von ARRIBA-Herz, einer Beratungsstrategie für die Herz-Kreislaufprävention [Evaluation of Complex Interventions: Implementation of ARRIBA-Herz, A Counseling Strategy for Coronary Prevention]. Sadowski EM, Eimer C, Keller H, Krones T, Sönnichsen AC, Baum E, Donner-Banzhoff N, Z Allgemeinmed 2005 81 429 34 10.1055/s-2005-872475 (Pubitemid 41569783)
19. Baden-Württemberg AOK, Geschäftsbericht 2011/2012 [Business Report 2011/2012] 2012 available from http://www.aok.de/assets/media/baden- wuerttemberg/gb-2011-12-bawue-rz-ansicht-gesamt-11102012.pdf 23097536
20. Validation, updating and impact of clinical prediction rules: a review. Toll DB, Janssen KJM, Vergouwe Y, Moons KGM, J Clin Epidemiol 2008 61 1085 94 10.1016/j.jclinepi.2008.04.008 19208371
21. Kleinbaum DG, Klein M, Survival Analysis Springer-Verlag, New York 2 2005
22. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Harrell FE, Lee KL, Mark DB, Stat Med 1996 15 361 87 10.1002/(SICI)1097-0258(19960229)15:4<361:: AID-SIM168>3.0.CO;2-4 8668867 (Pubitemid 26072233)
23. Assessments tools for risk prediction of cardiovascular diseases. Gorenoi V, Schönermark MP, Hagen A, GMS Health Technology Assessment 2009 5 Doc11
24. Charakteristika von eingeschriebenen Versicherten eines flächendeckenden Vertrages zur hausarztzentrierten Versorgung [Characteristics of Beneficiaries of a GP-Centred Health Care Contract in Germany]. Freund T, Szecsenyi J, Ose D, Medizinische Klinik-Intensivmedizin und Notfallmedizin 2010 105 808 11 10.1007/s00063-010-1138-z
25. Administrative database research has unique characteristics that can risk biased results. van Walraven C, Austin P, J Clin Epidemiol 2012 65 126 31 10.1016/j.jclinepi.2011.08.002 22075111
26. Gesundheitsökonomische Evaluation auf Grundlage von GKV-Routinedaten [Health economic evaluation based on administrative data from German health insurance]. Schreyogg J, Stargardt T, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012 55 668 74 10.1007/s00103-012-1476-5 22526855